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Staphylococcus aureus is an important cause of infections and HIV-infected individuals are frequently
susceptible to this pathogen. The aim of this study was to perform a systematic review to identify both the risk
factors associated with colonization/infection by methicillin-resistant S. aureus in HIV patients and the methods
used for characterization of isolates. An electronic search of articles published between January 2001 and
December 2013 was first conducted. Among 116 studies categorized as being at a quality level of A, B or C, only
9 studies were considered to have high methodological quality (level A). The majority of these studies were
retrospective (4/9 studies). The risk factors associated with colonization/infection by S. aureus were use of
antimicrobials (4/9 studies), previous hospitalization (4/9 studies) and low CD4+ T lymphocyte counts
(,200 cells/ml) (3/9 studies). Culture in mannitol salt agar (3/9 studies) and the latex agglutination test (5/9
studies) were the main methods used for bacterial phenotypic identification. Genotypic profiles were accessed
by pulsed-field gel electrophoresis (6/9 studies) and USA300 was the most prevalent lineage (5/9 studies). Most
isolates were resistant to erythromycin (3/9 studies) and susceptible to vancomycin (4/9 studies). Ultimately, use
of antimicrobials and previous hospitalization were the main risk factors for colonization/infection by
methicillin-resistant S. aureus in HIV-infected individuals. However, the numbers of evaluated patients, the
exclusion and inclusion criteria and the characterization of the S. aureus isolates were not uniform, which made
it difficult to establish the characteristics associated with HIV patients who are colonized/infected by S. aureus.
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& INTRODUCTION
HIV/AIDS is characterized as a serious public health
problem and is considered as a major challenge worldwide
(1). According to the World Health Organization (2),
approximately 33.3 million people were infected with
HIV/AIDS in 2009 and it is estimated that a total of 2.6
million individuals are infected annually. In 2010, these
figures already exceeded 34 million infected individuals,
including adults and children.
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An infected person may not show any clinical symptoms
that are suggestive of the infection for years. However,
continued viral replication and the consequent decline in
CD4+ T cells may lead to the onset of clinical manifestations.
In addition, upon acquiring immunodeficiency, the infected
person becomes susceptible to the development of other
infections. In fact, bacterial infections are responsible for most
of the events that affect HIV-infected patients (3). Although
the use of antiretroviral therapy has improved this scenario, a
few pathogens can cause clinical complications, such as
Staphylococcus aureus. This pathogen, which has been identi-
fied as being responsible for morbidity and mortality among
HIV patients, produces important virulence factors and
frequently acquires resistance to different antibiotics (4,5).
Methicillin-resistant S. aureus (MRSA) expresses an
additional penicillin-binding protein, PBP2a, which is
encoded by the mecA gene. This gene is located in a mobile
genetic element referred to as staphylococcal chromosomal
cassette mec (SCCmec) (6). SCCmec types II and III are
commonly associated with hospital-acquired isolates,
whereas community-acquired isolates normally carry type
IV or V (7,8).
Decreased host immunity among HIV-infected patients
places them at increased risk for several infections, includ-
ing those caused by S. aureus and MRSA. Certain authors
have evaluated the risk factors related to infection and/or
colonization of HIV-infected individuals with S. aureus and
have shown the importance of various behavioral and
clinical aspects (9-11). However, only few studies have used
microbiological methods to characterize isolates to validate
of their data (9,10). Thus, this systematic review aimed to
determine both the risk factors associated with coloniza-
tion/infection by MRSA in HIV-infected individuals and
the methods used for characterization of isolates.
& MATERIALS AND METHODS
The present study may be characterized as a descriptive,
exploratory and systematic literature review. This review
was conducted by two examiners, who performed a non-
biased analysis of the studies selected based on the inclusion
and exclusion criteria described below.
The search covered articles published between January
2001 and December 2013 in five online health sciences
databases: PubMed, the Scientific Electronic Library Online
(SciELO), the Latin American and Caribbean Health Sciences
(LILACS) database, Ovid, Google Scholar. The search was
conducted using six keywords: ‘‘MRSA, methicillin-resistant
Staphylococcus aureus’’, ‘‘HIV’’, ‘‘Staphylococcus’’, ‘‘recurrent
infections’’, ‘‘molecular typing’’ and ‘‘epidemiology’’. These
keywords were selected as being reflective of the topic of
interest, as analyzed previously using the Medline MeSH.
Articles were selected from each database based on the
following inclusion criteria: a title and abstract compatible
with the given subject; published within the last 13 years
(from January 1, 2001 to December 31, 2013); published in
Portuguese, English or Spanish; and based on original
research. Articles were excluded when the main subject was
not compatible with the aim of the present study (such as
phytochemistry, biology of lymphocytes and kidney dis-
ease, among other topics); when they were published more
than 13 years ago; when they dealt with S. aureus-related
infections in bone or gynecological areas or with endocar-
ditis, which have characteristics that distinguish them from
other infections; when their links for online access had no
data available for consultation; and when they were case
reports, literature reviews, book chapters, theses or letters to
the editor.
Papers that fulfilled the selection criteria were analyzed
for their methodological quality using a quality assessment
questionnaire based on criteria established by the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISM) statement. The scores for determining
the presence of features regarded as important in the study
are shown in Table 1. In this classification, each item
presented by a study corresponds to a score of one. The
studies that received scores between 8 and 10 were
classified as level A, which indicates high methodological
quality and studies that had scores of 5 to 7 points were
classified as level B, implying intermediate methodological
quality. Meanwhile, scores of less than or equal to 4 points
were included in level C, indicating low methodological
quality. Only studies classified as level A were included in
the current review.
& RESULTS
Figure 1 outlines the steps for the selection of the studies.
The number of articles found in and selected from the
databases is listed in Table 2. An initial electronic search of
the health sciences databases using the keywords uncovered
a total of 911, 29, 841, 11 and 1,115 articles from PubMed,
SciELO, LILACS, Ovid and Google Scholar, respectively.
After applying the inclusion and exclusion criteria, 67
studies were selected and analyzed for quality. The quality
assessment revealed 9 papers in category A, which were
Table 1 - Quality evaluation criteria and their scores.*
Number Quality Assessment Yes No
1 Representative sample of the target population 1 0
2 Definition of the type of study 1 0
3 Definition of the inclusion and exclusion criteria applied to the sample 1 0
4 Presence of a control group 1 0
5 Description of risk factors for colonization and/or infection 1 0
6 Phenotypic analysis: Gram staining and catalase and coagulase tests 1 0
7 Molecular analysis: SCCmec (typing), PFGE and MLST 1 0
8 Antimicrobial susceptibility analysis: MIC and disk diffusion tests 1 0
9 Statistical analysis 1 0
10 Discussion of the limitations of the study 1 0
*Based on criteria established by the PRISM statement. SCCmec: staphylococcal cassette chromosome mec; PFGE: pulsed-field gel electrophoresis; MLST:
multilocus sequence typing; MIC: minimum inhibitory concentration.
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included in the present systematic review (Table 3). Of these
papers, eight received 8 points and only one received 9
points. The data from the selected studies are listed in
Table 3. Among the most relevant data, the size of the target
population was considered to be very discrepant, ranging
from 107 to 4,674 patients.
The study designs were mostly retrospective (4/9 studies)
and the most common risk factors associated with coloniza-
tion/infection were previous use of antimicrobials (4/9
studies), previous hospitalization (4/9 studies) and the
CD4+ T lymphocyte count (typically ,200 cells/ml) (3/9
studies) (Table 3).
The main methodologies used for S. aureus phenotypic
identification were culture in salt mannitol agar (3/9
studies) and the latex agglutination test (5/9 studies),
which was used for the detection of the clumping factor or
bound coagulase. Pulsed-field gel electrophoresis (PFGE)
was the main molecular analytical method used to define
the search community/hospital clones (6/9 studies) and
the USA300 lineage was considered to be the most
prevalent in the majority of the articles that assessed the
clonality of isolates. The exception was a study performed
by Gordon et al. (2010) from New York, USA, which found
a larger number of isolates related to the USA500 lineage, a
hospital clone.
Susceptibility, as determined by the disk diffusion test,
was evaluated in only 3 of the 9 studies. However, 5 studies
determined the minimum inhibitory concentration (MIC) or
the susceptibility of isolates using an automated technique.
MRSA isolates were detected and analyzed by the authors
of 6 of the 9 selected papers, whereas the other 3 studies
were retrospective, evaluating data from laboratory and
hospital databases. The studies that evaluated antimicrobial
resistance described erythromycin-resistant S. aureus (3/9
studies), vancomycin-susceptible S. aureus (4/9 studies)
and/or rifampicin-susceptible S. aureus (3/9 studies). Two
studies also performed SCCmec typing and found that type
IV was a common or unique cassette among MRSA isolates.
Figure 1 - Outline of the steps for the selection of the studies.
Table 2 - Databases and search results.
Reference source Keywords
Total
articles
Articles found after applying the
inclusion and exclusion criteria
Articles selected based
on quality assessment
PubMed HIVc; Staphylococcus; MRSAd 911 23 9
SciELOa HIV; Staphylococcus; MRSA 29 12 0
LILACSb HIV; Staphylococcus; MRSA 841 17 0
Ovid HIV; Staphylococcus; HIV; MRSA 11 5 0
Google Scholar MRSA; HIV; recurrent infections;
molecular typing; epidemiology
1.115 10 8
aScientific Electronic Library Online;
bLatin American and Caribbean Health Sciences;
chuman immunodeficiency virus;
dmethicillin-resistant Staphylococcus aureus.
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& DISCUSSION
The use of HAART has increased the life expectancy of
HIV-infected patients, whether pediatric or adult, via the
reduction of opportunistic infections, with a consequent
improvement in quality of life (13). In this context, it
remains unclear whether these patients have an increased
risk of these microbial infections due to a higher prevalence
of colonization by pathogens or due to other factors.
Therefore, knowledge of the risk factors that may favor
colonization is critical to develop strategies to prevent
colonization and infection in patients and their contacts
(4,9,14,15). In the current systematic review, both the risk
factors associated with colonization/infection by MRSA in
HIV-infected individuals and the methods for characteriza-
tion of this pathogen were evaluated.
Among the 9 studies that qualified for this review, 2 were
conducted in Europe and 7 were conducted in North
America. In 4 of these studies, use of antibiotics was
detected as an important risk factor for S. aureus infections
in HIV-positive individuals (9,16-18). In addition, most of
these isolates were MRSA, suggesting that the use of
antibiotics can lead to the selection of resistant microorgan-
isms. However, there was no consensus among the authors
about previous exposure to antibiotics during sampling
(9,16-18). Thus, although it has been well established that
prior antimicrobial therapy is a risk factor for MRSA
colonization/infection, it is difficult to determine exactly
what duration of antibiotic use may be considered as a risk
factor.
Previous hospitalization (15,18,19) and invasive medical
procedures (19) were also described as risk factors for the
acquisition of MRSA by HIV patients. In particular, a
multivariate analysis showed that HIV patients hospitalized
for more than five days had a 14% increased risk of
acquiring MRSA (19). Other factors, such as diabetes (20),
previous infections or co-infections (including skin and soft
tissue infections) (15,16,18), co-morbidities (20) and a
history of colonization and infection by MRSA (15), were
also reported as risk factors for acquiring this pathogen.
Certain behavioral risk factors have also been associated
with colonization by MRSA, including imprisonment (18),
alcohol abuse (18), heterosexual behavior (20), homeless-
ness (18) and illicit drug use (17,18). Although excluded
based on its quality criteria, a study by Mimiaga et al.
reported that crystal methamphetamine users are more
likely to have multiple partners and to engage in risky
sexual intercourse (21). Similarly, strong associations
between HIV infection, use of injectable drugs and the
development of bacteremia caused by MRSA have been
shown (20).
The samples selected for these types of studies should be
clearly representative of the target population of HIV-
infected individuals. However, in the present review, the
majority of the studies selected their samples from a single
institution, without sample calculation, which may be
related to the convenience of sample collection or to a low
number of cases. The resultant variation made the data
analyses challenging. Moreover, certain studies used only
one sample (one clinical specimen per patient), whereas
others used more than one sample per patient (9,11,15-
17,20,22,23), making the analysis difficult. Additionally,
there were differences in the type of design used among the
studies analyzed.T
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In the present review, nearly half of the articles (3/9
studies) used culture in selective media (mannitol salt agar),
followed by the latex agglutination test, to identify S. aureus
isolates. Although latex tests are simple and rapid, they do
not present 100% sensitivity (24) because other species, such
as S. lugdunensis, that are positive for clumping factor may
be misidentified as S. aureus using this test (25). In contrast,
the coagulase tube test, which is a more reliable method for
identifying S. aureus, was not performed in any of the
studies evaluated in this review (24).
The disk diffusion test, which was used in only three
studies (15,17,26), is the simplest and least expensive assay
and presents high sensitivity and specificity for detecting
MRSA isolates (28). However, MIC determination and
oxacillin agar screening (OAS) were also used to determine
the methicillin resistance in several studies (9,15-17,20).
Although these procedures are recommended by CLSI
(2009) (12), MIC determination is usually more laborious
than other techniques and OAS presents low sensitivity and
may be unable to detect SCCmec IV isolates (28). It is
important to mention that SCCmec IV is traditionally found
in community-acquired MRSA isolates and in specific risk
groups, such as children, athletes, members of the military
and men who have sex with men (29). However, in this
review, only two studies performed SCCmec typing and
they found that type IV was a common (15) or unique
cassette (9) among the analyzed MRSA isolates.
Six studies employed PFGE to verify the clonality of the
MRSA isolates obtained from their samples. The USA300
clone was the most common lineage, found in four studies
(9,18,26,27), whereas Hidron et al. detected isolates of the
USA300 (30.8%), USA100 (40.4%) and USA500 (19.2%)
lineages (15). The USA500 clone was also detected among
15% of MRSA isolates in the study conducted by Gordon et
al. (17). The USA100 and USA500 isolates, which carry
SCCmec II and I, respectively, were the most common
lineages recovered from hospital-acquired infections in the
USA and Europe, respectively, in the past decade. However,
these lineages are currently being replaced by other lineages
that were once limited to the community, such as USA300/
SCCmec IV (30). In the USA, where all studies that applied
the PFGE technique were conducted, the USA300 clone is
considered to be the predominant cause of community-
acquired S. aureus infections and colonization (30,31),
confirming the findings demonstrating that the USA300
lineage is more frequent among HIV patients. In contrast, in
other geographical regions, such as Brazil, Australia and
eastern Asia, USA300 is rarely found (32). In these localities,
other lineages are spreading throughout the community
(30,33). Thus, more studies examining the prevalence of
MRSA isolates from HIV patients around the world should
be performed to clarify the molecular epidemiology of
MRSA isolates recovered from patients in other countries.
The findings of the nine articles selected in this systematic
review indicate that the main risk factors for colonization/
infection by MRSA in HIV-infected individuals are use of
antimicrobials and previous hospitalization. However, the
numbers of evaluated patients, the exclusion and inclusion
criteria and the characterization of S. aureus isolates were
not uniform, limiting identification of the characteristics
associated with HIV patients who are colonized/infected by
S. aureus. Infections caused by MRSA isolates are an
important issue in the clinical management of HIV patients,
so more studies evaluating risk factors and the best
techniques to identify and characterize isolates from these
patients are necessary.
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